Änderungen

Zur Navigation springen Zur Suche springen
826 Bytes hinzugefügt ,  17:55, 19. Jul. 2008
Zeile 32: Zeile 32:  
*López-Lázaro M: The warburg effect: why and how do cancer cells activate glycolysis in the presence of oxygen? Anticancer Agents Med Chem. 2008 Apr;8(3)
 
*López-Lázaro M: The warburg effect: why and how do cancer cells activate glycolysis in the presence of oxygen? Anticancer Agents Med Chem. 2008 Apr;8(3)
 
*Chen Z, Lu W, Garcia-Prieto C, Huang P.: The Warburg effect and its cancer therapeutic implications. J Bioenerg Biomembr. 2007 Jun;39(3):267-74.
 
*Chen Z, Lu W, Garcia-Prieto C, Huang P.: The Warburg effect and its cancer therapeutic implications. J Bioenerg Biomembr. 2007 Jun;39(3):267-74.
 +
*Tim J. Schulz, René Thierbach, Anja Voigt, Gunnar Drewes, Brun Mietzner, Pablo Steinberg, Andreas F. H. Pfeiffer und Michael Ristow: „Induction of Oxidative Metabolism by Mitochondrial Frataxin Inhibts Cancer Growth: Otto Warburg Revisited", Journal of Biological Chemistry, Vol. 281, Nr. 2, 13.01.2006, Seiten 977–981. [http://www.jbc.org/cgi/reprint/M511064200v1]
 +
*René Thierbach, Tim J. Schulz, Frank Isken, Anja Voigt, Brun Mietzner, Gunnar Drewes, Jürgen-Christoph von Kleist-Retzow, Rudolf J. Wiesner, Mark A. Magnuson, Hélène Puccio, Andreas F.H. Pfeiffer, Pablo Steinberg und Michael Ristow: „Targeted Disruption of Hepatic Frataxin Expression Causes Impaired Mitochondrial Function, Decreased Life Span and Tumor Growth in Mice", Human Molecular Genetics, Vol. 14, Nr. 24, 15.12.2005, Seiten 3857–3864.
    
==Quellennachweise==
 
==Quellennachweise==
23.054

Bearbeitungen

Navigationsmenü